Pipline

Product

 Indications

Phase1
(basic science Research)

Phase2 
(pre-Clinical Testing)

Phase3
Clinical Trials

phase4 
(Gov't Approval)

     

 

SCB- Cannabis Extracts

ODD, Rare Disease (Orphan drug designation)  

SCB- 1159 (Neonatal Hypoxic-Ischemic Encephalopathy)

Yes

SCB- 1160 (Dravet syndrome)

Yes

SCB- 1161 (Lennox-Gastaut syndrome)

Yes

SCB- 1162 (Tuberous Sclerosis Complex)

Yes

SCB- 1163 (Early onset schizophrenia)

Yes